Showing results (2041-2050 of 2,175) with videos related to
Sort By:
Pageof 218
JAMA Ophthalmology|November 12, 2020
Retinal Imaging Findings in Carriers With PSEN1-Associated Early-Onset Familial Alzheimer Disease Before Onset of Cognitive SymptomsGrayson W Armstrong, Leo A Kim, Filippos Vingopoulos, et al.Journal of the American Academy of Dermatology|November 19, 2025
Joint position statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on routine testing for latent tuberculosis infection prior to and during treatment of psoriasis patients with interleukin 17 or interleukin 23 inhibitorsAndrew Blauvelt, Bruce E Strober, Guy S Eakin, et al.European Journal of Heart Failure|March 3, 2022
Vericiguat in patients with coronary artery disease and heart failure with reduced ejection fractionClara Saldarriaga, Dan Atar, Amanda Stebbins, et al.The New England Journal of Medicine|December 8, 2021
Phase 3 Trials of Tapinarof Cream for Plaque PsoriasisMark G Lebwohl, Linda Stein Gold, Bruce Strober, et al.The British Journal of Dermatology|August 28, 2025
SPECTREM Phase 3b Clinical Trial Results Through Week 16: Guselkumab Efficacy and Safety for the Treatment of Low Body Surface Area, Moderate Psoriasis With High-Impact Site InvolvementLinda Stein Gold, Alice B Gottlieb, April W Armstrong, et al.Journal of Thrombosis and Haemostasis : JTH|March 8, 2005
First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS TrialJ H Alexander, H Yang, R C Becker, et al.The American Journal of Cardiology|January 22, 2014
Association of aspirin dose and vorapaxar safety and efficacy in patients with non-ST-segment elevation acute coronary syndrome (from the TRACER Trial)Kenneth W Mahaffey, Zhen Huang, Lars Wallentin, et al.JACC. Heart Failure|February 16, 2024
Recurrent Hospitalizations and Response to Vericiguat in Heart Failure and Reduced Ejection FractionRobert J Mentz, Amanda Stebbins, Javed Butler, et al.Circulation. Heart Failure|May 18, 2019
Rationale and Design of the VITALITY-HFpEF TrialJaved Butler, Carolyn S P Lam, Kevin J Anstrom, et al.The Journal of Rheumatology|February 16, 2021
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) MeetingCarmel Stober, Deepak R Jadon, April W Armstrong, et al.Pageof 218